Home » Topics » BioWorld Science

BioWorld Science
RSS

SPRINT-MS trial: phase II results of ibudilast treatment in progressive multiple sclerosis

May 11, 2018

Shionogi recaps progress of fourth quarter of fiscal 2017

May 11, 2018

Intrommune Therapeutics launches financing campaign to support development of INT-301

May 11, 2018

CFDA clears HG-146 to enter clinical trials for multiple myeloma

May 11, 2018

LogicBio Therapeutics begins program for genome-editing therapy for methylmalonic acidemia

May 11, 2018

Gilead studies GS-9688 in virally suppressed patients with chronic HBV infection

May 10, 2018

YL Biologics and Kyowa submit Japanese NDA for etanercept biosimilar YLB-113

May 10, 2018

FDA grants orphan drug designation to Cellectar's CLR-131 for rhabdomyosarcoma

May 10, 2018

Sellas' galinpepimut-S awarded FDA orphan drug designation for multiple myeloma

May 10, 2018

MediciNova cleared to study ibudilast for glioblastoma

May 10, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...